The Buprenorphine Market is estimated to be valued at US$ 3,681.9 million in 2020 and is expected to exhibit a CAGR of 14.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Buprenorphine is a partial opioid agonist used to treat opioid addiction. It works by binding to and activating opioid receptors in the brain to decrease ... Read more
